BlackRock’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$213M Sell
7,418,715
-237,854
-3% -$6.84M ﹤0.01% 1578
2025
Q1
$257M Buy
7,656,569
+141,376
+2% +$4.74M 0.01% 1442
2024
Q4
$384M Buy
7,515,193
+965,251
+15% +$49.4M 0.01% 1246
2024
Q3
$335M Buy
6,549,942
+319,571
+5% +$16.3M 0.01% 1344
2024
Q2
$279M Buy
6,230,371
+794,267
+15% +$35.6M 0.01% 1392
2024
Q1
$254M Buy
5,436,104
+90,990
+2% +$4.26M 0.01% 1477
2023
Q4
$190M Buy
5,345,114
+499,397
+10% +$17.8M ﹤0.01% 1663
2023
Q3
$144M Buy
4,845,717
+245,231
+5% +$7.29M ﹤0.01% 1751
2023
Q2
$82.9M Buy
4,600,486
+644,128
+16% +$11.6M ﹤0.01% 2139
2023
Q1
$63.5M Buy
3,956,358
+38,869
+1% +$624K ﹤0.01% 2260
2022
Q4
$71.7M Buy
3,917,489
+165,467
+4% +$3.03M ﹤0.01% 2212
2022
Q3
$73.7M Sell
3,752,022
-37,461
-1% -$736K ﹤0.01% 2141
2022
Q2
$70.7M Buy
3,789,483
+492,703
+15% +$9.19M ﹤0.01% 2233
2022
Q1
$72.4M Buy
3,296,780
+20,610
+0.6% +$452K ﹤0.01% 2320
2021
Q4
$93.1M Buy
3,276,170
+659,331
+25% +$18.7M ﹤0.01% 2240
2021
Q3
$55.1M Buy
2,616,839
+23,453
+0.9% +$494K ﹤0.01% 2568
2021
Q2
$48.9M Buy
2,593,386
+426,878
+20% +$8.05M ﹤0.01% 2681
2021
Q1
$33.1M Buy
2,166,508
+53,313
+3% +$815K ﹤0.01% 2846
2020
Q4
$29.8M Buy
2,113,195
+314,497
+17% +$4.44M ﹤0.01% 2739
2020
Q3
$28.2M Buy
1,798,698
+30,829
+2% +$483K ﹤0.01% 2604
2020
Q2
$31M Buy
1,767,869
+1,045,566
+145% +$18.3M ﹤0.01% 2521
2020
Q1
$10.6M Sell
722,303
-9,752
-1% -$143K ﹤0.01% 2915
2019
Q4
$18.4M Sell
732,055
-231,947
-24% -$5.82M ﹤0.01% 2893
2019
Q3
$14.5M Buy
964,002
+31,578
+3% +$475K ﹤0.01% 2971
2019
Q2
$23.3M Buy
932,424
+154,450
+20% +$3.86M ﹤0.01% 2742
2019
Q1
$17.7M Buy
777,974
+84,802
+12% +$1.93M ﹤0.01% 2796
2018
Q4
$20.8M Buy
693,172
+273,886
+65% +$8.21M ﹤0.01% 2694
2018
Q3
$12M Buy
+419,286
New +$12M ﹤0.01% 3118